Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Novo Nordisk’s Saxenda has been recommended by NICE as ... product which requires dosing by injection every day. Ozempic is squaring off in the market against Eli Lilly’s Trulicity ...

Brandon Lake Last week Weeks at no. 1 Weeks on chart B.M.Lake, S.Furtick, B.W.Hastings, C.J.Brown M.Nichols Brandon Lake/Essential/PLG Biggest gain in digital sales Gains In Performance ...

Dosing a statin (rosuvastatin ... and the Hartford Hospital Cholesterol Management Center. Approximately 2600 charts were reviewed to identify patients receiving rosuvastatin EOD who previously ...

The week's most popular developing artists, using the same formula as the all-encompassing Billboard Artist 100, which measures artist activity across multiple Billboard charts, including the ...

The FDA has expanded the labeling for Izervay (avacincaptad pegol) to include longer-term administration for geographic ...

The Official Film Chart is a rundown of the UK’s favourite films of the week, as bought on DVD, Blu-Ray and download and is compiled by the Official Charts Company, based on sales across a seven ...

Please note, the data displayed for this chart reflects the title's midweek position only, peak positions on this chart also relate to midweek chart positions. Official Singles Chart Update data ...